Ischemic Stroke Outcome and Early Infection: Its Deleterious Effect Seems to Operate Also among Tissue Plasminogen Activator-Treated Patients

Publisher： Karger

E-ISSN： 1421-9913|65|2|82-87

ISSN： 0014-3022

Source： European Neurology, Vol.65, Iss.2, 2011-01, pp. : 82-87

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Uric Acid Levels on Outcome in Severe Ischemic Stroke Patients Treated with Intravenous Recombinant Tissue Plasminogen Activator

By  

European Neurology, Vol. 71, Iss. 3-4, 2013-12 ,pp. : 132-139

Karger

Access to resources Recommend Favorite

Frequency and Predictors of Symptomatic Intracerebral Hemorrhage in Patients with Ischemic Stroke Treated with Recombinant Tissue Plasminogen Activator outside Clinical Trials

By  

Cerebrovascular Diseases, Vol. 23, Iss. 2-3, 2006-11 ,pp. : 85-90

Karger

Access to resources Recommend Favorite

Very Early versus Delayed Rehabilitation for Acute Ischemic Stroke Patients with Intravenous Recombinant Tissue Plasminogen Activator: A Nationwide Retrospective Cohort Study

By  

Cerebrovascular Diseases, Vol. 42, Iss. 1-2, 2016-03 ,pp. : 41-48

Karger

Access to resources Recommend Favorite

Centenarian Stroke Treated with Tissue-Type Plasminogen Activator

By  

Cerebrovascular Diseases, Vol. 13, Iss. 4, 2002-05 ,pp. : 285-287

Karger

Access to resources Recommend Favorite

Does Current Oral Antiplatelet Agent or Subtherapeutic Anticoagulation Use Have an Effect on Tissue-Plasminogen-Activator-Mediated Recanalization Rate in Patients with Acute Ischemic Stroke?

By  

Cerebrovascular Diseases, Vol. 30, Iss. 5, 2010-09 ,pp. : 508-513

Karger

Access to resources Recommend Favorite